Search Results Search Sort by RelevanceMost Recent Podcast Jun 2019 Ethics Talk: What Are Clinicians’ Obligations to Patients Who Express Bias or Discrimination? When a patient’s preference expresses injustice, how should clinicians respond? We discuss individual and organizational responses. Medicine and Society Aug 2019 Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? Michael J. DiStefano, MBE and Jonathan S. Levin, MPH Advances in CEA methodology might integrate equity at the cost of transparency. AMA J Ethics. 2019;21(8):E679-685. doi: 10.1001/amajethics.2019.679. Case and Commentary Aug 2019 How Should Physicians Steward Limited Resources While Ensuring That Patients Can Access Needed Medicines? Pete Croughan and Rebekah E. Gee, MD, MPH Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients. AMA J Ethics. 2019;21(8):E630-635. doi: 10.1001/amajethics.2019.630. State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645. Policy Forum Aug 2019 Why Are Biosimilars Not Living up to Their Promise in the US? Mike Z. Zhai, Ameet Sarpatwari, JD, PhD, and Aaron S. Kesselheim, MD, JD, MPH Overall utilization of the few biosimilars currently available to patients has been limited. AMA J Ethics. 2019;21(8):E668-678. doi: 10.1001/amajethics.2019.668. AMA Code Says Aug 2019 AMA Code of Medical Ethics’ Opinions Related to Prescription Drugs Rachel F. Harbut and Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics offers guidance on stewardship and professionalism. AMA J Ethics. 2019;21(8):E642-644. doi: 10.1001/amajethics.2019.642. State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654. Medicine and Society Sep 2019 Is Updating the WMA Physician’s Pledge Enough? Ben Bowman and Brian Callender, MD Changes made in 2017 to the World Medical Association Physician’s Pledge strive to keep in step with geopolitical trends by addressing patient autonomy and collegiality. AMA J Ethics. 2019;21(9):E796-800. doi: 10.1001/amajethics.2019.796. Case and Commentary Sep 2019 What Are Criteria for Considering Technologies’ Uses and Influences in LMICs’ Health Care Infrastructures? Rolvix Patterson and Richard Rohrer, MD Low-resource areas are heterogeneous and changing, so establishing an evidence base for decision making about technology use is an important priority. AMA J Ethics. 2019;21(9):E735-741. doi: 10.1001/amajethics.2019.735. Health Law Jan 2019 April 2018 Flores Settlement Suit Challenges Unlawful Administration of Psychotropic Medication to Immigrant Children Scott J. Schweikart, JD, MBE What should happen when drugs given to detained children without parental consent compromise their best interests? AMA J Ethics. 2019;21(1):E67-72. doi: 10.1001/amajethics.2019.67. Pagination First page « First Previous page ‹ Previous … Page 2 Page 3 Page 4 Page 5 Current page 6 Page 7 Page 8 Page 9 Page 10 … Next page Next › Last page Last »
Podcast Jun 2019 Ethics Talk: What Are Clinicians’ Obligations to Patients Who Express Bias or Discrimination? When a patient’s preference expresses injustice, how should clinicians respond? We discuss individual and organizational responses.
Medicine and Society Aug 2019 Does Incorporating Cost-Effectiveness Analysis Into Prescribing Decisions Promote Drug Access Equity? Michael J. DiStefano, MBE and Jonathan S. Levin, MPH Advances in CEA methodology might integrate equity at the cost of transparency. AMA J Ethics. 2019;21(8):E679-685. doi: 10.1001/amajethics.2019.679.
Case and Commentary Aug 2019 How Should Physicians Steward Limited Resources While Ensuring That Patients Can Access Needed Medicines? Pete Croughan and Rebekah E. Gee, MD, MPH Louisiana has a subscription model for hepatitis C treatment, but costly medications challenge states’ capacities to cover patients. AMA J Ethics. 2019;21(8):E630-635. doi: 10.1001/amajethics.2019.630.
State of the Art and Science Aug 2019 Evolving Medicaid Coverage Policy and Rebates Jennifer A. Ohn, MPH and Anna Kaltenboeck, MA Ethics questions arise about the usefulness of a system that pegs Medicaid drug spending to net prices negotiated by others in the market. AMA J Ethics. 2019;21(8):E645-653. doi: 10.1001/amajethics.2019.645.
Policy Forum Aug 2019 Why Are Biosimilars Not Living up to Their Promise in the US? Mike Z. Zhai, Ameet Sarpatwari, JD, PhD, and Aaron S. Kesselheim, MD, JD, MPH Overall utilization of the few biosimilars currently available to patients has been limited. AMA J Ethics. 2019;21(8):E668-678. doi: 10.1001/amajethics.2019.668.
AMA Code Says Aug 2019 AMA Code of Medical Ethics’ Opinions Related to Prescription Drugs Rachel F. Harbut and Danielle Hahn Chaet, MSB The AMA Code of Medical Ethics offers guidance on stewardship and professionalism. AMA J Ethics. 2019;21(8):E642-644. doi: 10.1001/amajethics.2019.642.
State of the Art and Science Aug 2019 Are Medicaid Closed Formularies Unethical? Leah Rand, DPhil and Govind Persad, JD, PhD Closed formularies can be justified when they enable spending on other socially valuable aims, but they can single out poor patients. AMA J Ethics. 2019;21(8):E654-660. doi: 10.1001/amajethics.2019.654.
Medicine and Society Sep 2019 Is Updating the WMA Physician’s Pledge Enough? Ben Bowman and Brian Callender, MD Changes made in 2017 to the World Medical Association Physician’s Pledge strive to keep in step with geopolitical trends by addressing patient autonomy and collegiality. AMA J Ethics. 2019;21(9):E796-800. doi: 10.1001/amajethics.2019.796.
Case and Commentary Sep 2019 What Are Criteria for Considering Technologies’ Uses and Influences in LMICs’ Health Care Infrastructures? Rolvix Patterson and Richard Rohrer, MD Low-resource areas are heterogeneous and changing, so establishing an evidence base for decision making about technology use is an important priority. AMA J Ethics. 2019;21(9):E735-741. doi: 10.1001/amajethics.2019.735.
Health Law Jan 2019 April 2018 Flores Settlement Suit Challenges Unlawful Administration of Psychotropic Medication to Immigrant Children Scott J. Schweikart, JD, MBE What should happen when drugs given to detained children without parental consent compromise their best interests? AMA J Ethics. 2019;21(1):E67-72. doi: 10.1001/amajethics.2019.67.